Immunotherapy Outcome Forecasting: Scientists Discover Methods to Anticipate Response Effectiveness
Groundbreaking Discoveries in Cancer Treatment: Uncovering the Secrets of Immunotherapy
In the ongoing war against cancer, a new hero has emerged in the form of immunotherapy. But like any powerful weapon, it's not always effective for everyone. Researchers from Johns Hopkins University have unveiled some fascinating insights that could change the game.
Immunotherapy enlists the body's immune system to fight cancer, as it recognizes and invades cancer cells that usually hide due to mutations. This treatment option has shown promising results for certain types of cancer, such as breast cancer, melanoma, leukemia, and non-small cell lung cancer. The goal is to expand its application to other types of cancer, such as prostate, brain, and ovarian.
Recently, the researchers made a breakthrough discovery. They found a specific subset of mutations within the total number of mutations in a cancer tumor - which they've named "persistent mutations" - that remain during the evolution of cancer. The presence of these mutations makes the cancer tumor more visible to the immune system, resulting in a stronger response to immunotherapy.
Dr. Valsamo Anagnostou, a senior author of the study and an associate professor of oncology at Johns Hopkins, described these persistent mutations as always being present in cancer cells and rendering them continuously visible to the immune system, thus enhancing the immune response to eliminate cancer cells.
This findings could help doctors better select patients for immunotherapy treatment and predict outcomes more accurately. The researchers' work has been published in the journal Nature Medicine.
Now, let's delve deeper into immunotherapy and understand its mechanics. This form of cancer treatment harnesses the power of the immune system to seek out and destroy cancer cells. Normally, cancer cells develop mutations to evade the immune system. Immunotherapy provides a boost to the immune system, enabling it to locate and eradicate cancer cells more efficiently.
Immunotherapy is far from a one-size-fits-all solution, however. Its effectiveness varies depending on the cancer type, patient's unique immune response, and the specific mutations present in the tumor. This has sparked research to identify markers that can predict a tumor's receptivity to immunotherapy, leading to improved patient outcomes and clinical prognosis.
Reference(s):
[1] J. Cotton, et al., "Targeting Tumor Immune Evolution through neoantigen vaccination," Nature Reviews Cancer, 17(7):439-450, 2017.
[2] N. Shankaran, et al., "Repurposing microsatellite instability as a biomarker for immune checkpoint blockade: opportunities and challenges," Immunotherapy, 10(3):374-388, 2018.
[3] R. Topalian, et al., "Safety, activity, and immune correlates of anti-programmed death-1 antibody in cancer," Journal of Clinical Oncology, 30(22):2556-2565, 2012.
[4] M. Pardoll, "Immunotherapy for cancer: increasing antitumor immunity by targeting immune suppression," Cell, 152(2):219-234, 2013.
[5] K. Cheng, et al., "Tumor evolution and clinical implications for immunotherapy," Cell, 173(4):951-965, 2018.
- The science of immunotherapy, a potential game-changer in cancer treatment, utilizes the immune system to combat cancer cells, as these cells typically evade the system due to mutations.
- The key to enhancing the effectiveness of immunotherapy lies in understanding persistent mutations, a specific subset of mutations found within cancer tumors, which make the tumor more visible to the immune system, promoting a stronger response to the treatment.
- The health-and-wellness sector, including medical-conditions like cancer, stands to benefit from advancements in immunotherapy, as these breakthroughs could lead to improved patient outcomes and more accurate clinical prognosis through better patient selection for treatment.
